CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,001 enrolled
Drug / intervention
Pegaptanibdrug
Likely dose
Pegaptanib 0.3 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01245387
NCT01245387N/ACompleted
CompareCT.gov

Long-Term Non-Interventional Study (AB Study) To Investigate The Efficacy And Safety Of Macugen® In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Pfizer·observational·Posted Nov 22, 2010·Updated Jan 13, 2011

In Brief

An observational study evaluating Pegaptanib for Macular Degeneration and 2 related conditions. Completed, enrolled 1,001 participants.

Detailed Summary

Long-term observational study to assess the safety, efficacy and quality of life of patients with neovascular age-related macular degeneration (AMD) under Macugen treatment.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMacular Degeneration, Age-related Macular Degeneration, Neovascular Macular Degeneration
Countries--
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 22, 2010
Enrollment StartAug 1, 2006
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.6 years ago

Interventions

Pegaptanibdrug

Dosage recommendations for MACUGEN took place on the basis of the approved Summary of Product Characteristics (SmPC) and were adjusted solely according to medical practice. MACUGEN® is available as pre-filled syringe containing 0.3 mg MACUGEN® in 90 µL injection solution for intravitreal injection. Macugen injections were documented to reflect the routine clinical practice. Follow-up visits were only carried out and documented if they took place as part of the standard medical treatment for the respective case and were necessary for medical and/or therapeutic reasons.